Sort
30,917 grants matching “tumor microenvironment”
TET2-mediated epitranscriptomic regulation in leukemia microenvironment
$650,167Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Mechanisms of tumorigenesis in Brg1 mutant lung cancer
$650,128Carla F. Kim · Boston Children'S Hospital · R01 · FY2021 · CA
The role of biobehavioral factors and anti-inflammatory medications on the ovarian tumor immune response
$650,127Shelley S Tworoger · Oregon Health & Science University · R01 · FY2025 · CA
Exploiting A Critical Vulnerability To Glutamine Antimetabolite Therapy in Fibrolamellar Hepatocellular Carcinoma (FLC)
$650,089Mark Yarchoan · Johns Hopkins University · R01 · FY2024 · CA
Imaging tumor and T cell responses to metabolic and immune modulation therapy
$650,075Taha Merghoub · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
$650,064Anna Karolina Palucka · Jackson Laboratory · R01 · FY2019 · CA
Nutrient Regulation of Cancer Cell Growth
$649,928Heather Christofk · University Of California Los Angeles · R01 · FY2025 · CA
Toward translation of a plant virus-based in situ vaccination nanotechnology
$649,918Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2022 · CA
Novel Targets for Vaccine Therapy
$649,875Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Developing a Translation Pipeline for VHL Mutant Malignancies
$649,803David McDermott · Beth Israel Deaconess Medical Center · U01 · FY2019 · CA
Multiscale Models of Wound Cell Plasticity for Regeneration
$649,767Qing Nie · University Of California-Irvine · U01 · FY2022 · AR
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy
$649,712Karl T Kelsey · Brown University · R01 · FY2023 · CA
Targeting DHX9 to trigger viral mimicry and immunotherapy responsiveness in Small Cell Lung Cancer (SCLC)
$649,679Israel Canadas · Research Inst Of Fox Chase Can Ctr · R37 · FY2024 · CA
Targeting DHX9 to trigger viral mimicry and immunotherapy responsiveness in Small Cell Lung Cancer (SCLC)
$649,679Israel Canadas · Research Inst Of Fox Chase Can Ctr · R37 · FY2025 · CA
The Role of Kaiso as a predictive breast cancer biomarker in Africa and across the African Diaspora
$649,645Kevin L. Gardner · Columbia University Health Sciences · R01 · FY2022 · CA
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort
$649,634Susan L. Neuhausen · Beckman Research Institute/City Of Hope · R01 · FY2022 · ES
A Statistical Physics Framework for Understanding the Role of Repeat RNA in Tumor Immunity
$649,506Benjamin Greenbaum · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA
Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping
$649,473Jun Yan · University Of Louisville · R01 · FY2024 · CA
Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping
$649,473Jun Yan · University Of Louisville · R01 · FY2025 · CA
Angiogenesis and Tumor Growth
$649,371Giovanna Tosato · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
The Emphysematous Microenvironment Promotes Lung Tumorigenesis and Progression
$649,363John J Reilly · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · HL
Therapeutic targeting mesenchymal transition in newly diagnosed and recurrent GBM
$649,226Frank Furnari · University Of California, San Diego · R01 · FY2024 · NS
Creation of in vivo active chemical probes for CAMKK2 to treat cancer
$649,225David Harold Drewry · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
Modulation of Therapeutic Response
$649,179James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA
Dynamics in the Tissue State: From Normal to Tumor and Back
$649,167Jan T. Liphardt · University Of California Berkeley · U54 · FY2010 · CA